Small intestine submucosa as a growth factor attractor promotes peripheral nerve regeneration by enhancing syndecan-3/glial cell line-derived neurotrophic factor (GDNF) signalling: in vivo study

Biomed Mater. 2023 Jul 12;18(5). doi: 10.1088/1748-605X/acdeb9.

Abstract

Peripheral nerve regeneration (PNR) following trauma requires the reconstruction of the extracellular matrix (ECM) and the proper stimulation of growth factors. Decellularised small intestine submucosa (SIS) has been extensively used as an ECM scaffold for tissue repair, but its potential to enhance the effects of exogenous growth factors on PNR is not well understood. In this study, we evaluated the effects of SIS implantation combined with glial cell-derived growth factor (GDNF) treatment on PNR in a rat neurorrhaphy model. We found that both SIS and regenerating nerve tissue expressed syndecan-3 (SDC3), one of major heparan sulphate proteoglycans in nerve tissue, and that SDC3 interacted with GDNF in the regenerating nerve tissue. Importantly, the SIS-GDNF combined treatment enhanced the recovery of neuromuscular function andβ3-tubulin-positive axonal outgrowth, indicating an increase in the number of functioning motor axons connecting to the muscle after neurorrhaphy. Our findings suggest that the SIS membrane offers a new microenvironment for neural tissue and promotes neural regeneration based on SDC3-GDNF signalling, providing a potential therapeutic approach for PNR.

Keywords: end-to-side neurorrhaphy; glial cell-derived growth factor (GDNF); nerve regeneration; peripheral nerve injury; small intestine submucosa; syndecan-3 (SDC3).

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Glial Cell Line-Derived Neurotrophic Factor*
  • Intestine, Small
  • Nerve Regeneration
  • Peripheral Nerves*
  • Rats
  • Syndecan-3

Substances

  • Glial Cell Line-Derived Neurotrophic Factor
  • Syndecan-3